According to Fortune Business Insights, the global cord blood banking services market was valued at USD 1.18 billion in 2025. The market is projected to grow from USD 1.24 billion in 2026 to USD 2.04 billion by 2034, registering a compound annual growth rate (CAGR) of 6.4% during the forecast period. North America dominated the market with a share of 38.14% in 2025.

Cord blood banking services involve the collection, transportation, processing, testing, cryogenic preservation, and storage of blood obtained from the umbilical cord and placenta following childbirth. Cord blood contains hematopoietic stem cells that can be used in selected medical treatments, including transplantation for certain blood cancers, genetic disorders, immune deficiencies, and metabolic conditions.

Growing awareness of stem cell preservation, advancements in biotechnology, and increasing demand for transplant-ready stem cell sources are supporting market expansion. Public, private, and hybrid banking institutions are strengthening their services to meet evolving healthcare requirements.

Key Market Growth Drivers

Increasing Demand for Stem Cell Transplantation

The growing demand for stem cell transplantation is an important driver of the cord blood banking services market. Cord blood provides an alternative source of hematopoietic stem cells for patients requiring transplantation. These cells can support the treatment of selected hematological malignancies, inherited blood disorders, and immune deficiencies.

Cord blood banking enables the preservation of potentially suitable stem cell units for future clinical use. Increasing awareness among healthcare professionals and patients regarding transplantation options is encouraging the development of banking infrastructure.

Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cord-blood-banking-services-market-118798

Rising Parental Awareness

Expectant parents are increasingly becoming aware of the potential benefits of preserving newborn cord blood. Private banking providers offer collection, processing, and long-term storage services to families interested in retaining biological materials for potential future medical applications.

Prenatal counseling, maternity hospital partnerships, and educational campaigns are helping improve awareness of cord blood preservation. Flexible payment plans and bundled storage services are also supporting customer participation.

Expansion of Public Cord Blood Banks

Public cord blood banks contribute to the availability of stem cell units for unrelated patients requiring transplantation. These banks collect and store donated cord blood that can be accessed through transplant registries.

Increasing efforts to improve donor diversity and expand public inventories are supporting market development. A broader inventory can improve the likelihood of finding suitable stem cell units for patients with diverse genetic backgrounds.

Advancements in Cryopreservation Technologies

Technological advancements in cryogenic storage, sample processing, and quality testing are improving the preservation of cord blood units. Automated processing systems and enhanced monitoring technologies help maintain sample integrity and reduce operational errors.

Digital tracking and electronic chain-of-custody systems are also improving transparency throughout collection, transportation, processing, and storage.

Expansion of Cord Tissue Banking

Cord tissue banking is gaining attention alongside conventional cord blood preservation. Cord tissue contains cells that are being investigated for potential applications in regenerative medicine.

Providers are increasingly offering combined cord blood and cord tissue banking packages. However, many cord tissue applications remain under investigation, and their future clinical utility is not guaranteed.

Market Segmentation

By Services

The market is segmented into collection and transportation, processing, analysis, storage, and others. Storage represents the leading service segment because preserved cord blood units require long-term cryogenic maintenance, monitoring, and documentation.

Collection and transportation services ensure safe sample handling after childbirth. Processing and analysis involve preparing samples, evaluating quality, and conducting relevant testing before preservation.

By Bank Type

The market includes private, public, and hybrid banks. Private banks accounted for the largest share, with a projected 65.4% market share in 2026. These institutions provide family-based preservation services through paid collection and long-term storage contracts.

Public banks preserve donated cord blood for potential use by unrelated patients. Hybrid banks combine private and public banking approaches, offering diversified service models.

By Component

The market is categorized into cord blood and cord tissue. Cord blood dominated the market, accounting for a projected 76.2% share in 2026. Its established role in hematopoietic stem cell transplantation supports continued demand.

Cord tissue banking is gaining interest because of ongoing research into regenerative medicine and cellular therapies.

By Application

Applications include cancer, genetic disorders, blood disorders, immune disorders, metabolic disorders, and others. Cancer represented the leading application segment, accounting for a projected 40.1% share in 2026.

Cord blood transplantation is used in selected hematological malignancies, including leukemia and lymphoma. Other applications include certain inherited blood conditions, immune deficiencies, and metabolic disorders.

By Service Provider

The market includes private banks, public banks, hospital-affiliated banks, hybrid banks, and others. Private banks accounted for a projected 55.7% share in 2026, supported by direct-to-consumer services and recurring storage contracts.

Regional Outlook

North America dominated the global cord blood banking services market with a value of USD 0.45 billion in 2025. Established banking infrastructure, strong private storage networks, and healthcare awareness support regional growth. The United States is projected to reach USD 0.43 billion in 2026.

Europe is expected to reach USD 0.21 billion in 2026, supported by established banking networks, recurring storage revenue, and increasing adoption of broader perinatal tissue services.

Asia Pacific is projected to reach USD 0.46 billion in 2026. Large birth populations, expanding healthcare infrastructure, and increasing awareness of stem cell preservation create opportunities across China, India, and Japan. China is projected to contribute approximately USD 0.23 billion in 2026.

Competitive Landscape

The market includes established cord blood banking companies and specialized healthcare service providers. Key companies identified by Fortune Business Insights include Cord Blood Registry (CBR), FamiCord AG, Shandong Cord Blood Bank, ViaCord, Beijing Cord Blood Bank, LifeCell International Pvt. Ltd., Cryo-Cell International, Inc., Cordlife Group Limited, and Shanghai Cord Blood Bank.

Companies compete through storage reliability, processing quality, collection networks, customer service, and regulatory compliance. Strategic partnerships and service expansion are important competitive approaches.

Challenges and Opportunities

High private banking costs, regulatory requirements, and uncertainty regarding future personal medical use remain significant challenges. Maintaining sample quality and reliable long-term storage also requires substantial investment.

Nevertheless, public inventory expansion, hybrid banking models, improved processing technologies, and growing interest in cellular therapies create opportunities for market participants.

Conclusion

The global cord blood banking services market is projected to grow from USD 1.18 billion in 2025 to USD 2.04 billion by 2034. Increasing demand for stem cell transplantation, parental awareness, and technological advancements are supporting market expansion. Despite affordability and regulatory challenges, continued developments in cord blood preservation and healthcare infrastructure are expected to create opportunities for industry participants worldwide.